| |
|
|
INDIANAPOLIS, IND. - Eli Lilly dedicated the Bioproduct Research and Development Laboratory in Indianapolis on May 12, 2008. The 475,000-sf, four-story facility will accommodate 500 scientists and staff in 33 labs engaged in biopharmaceutical research. The project represents the final phase of construction at Lilly’s three-building biotechnology complex. The first two phases include a 250,000-sf bioproduct manufacturing plant and a 10,000-sf research support facility, both completed in fall of 2006. Additionally, Lilly broke ground in April of 2008 on a €400 million biomanufacturing facility in Kinsale, Ireland.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more!
Sign Up Now!
|
|